278 Followers on Owler
OverviewCompetitorsFundingNews & Insights

Evommune Competitors or Alternatives

Evommune's top competitors include Ventyx, ValenzaBio and Vera.

Unlock 14 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

Evommune's company profile

Luis Pena

President & CEO

90/100
25 - 100
$268M
$100K - 5M
  • $268M
    $100K - 5M
  • 25 - 100
    $268M
  • $100K - 5M
  • 90/100
  • 25 - 100
  • $268M
  • $100K - 5M
View ProfileView
1
Evommune's Competitor - Ventyx logo

Raju Mohan

Founder & CEO

90/100
30
$520.5M
  • $520.5M
  • 30
    $520.5M
  • 90/100
  • 30
  • $520.5M
View ProfileView
2
Evommune's Competitor - ValenzaBio logo

Patrick J. Crutcher

Chairman & CEO

90/100
1 - 25
$84.5M
$100K - 5M
  • $84.5M
    $100K - 5M
  • 1 - 25
    $84.5M
  • $100K - 5M
  • 90/100
  • 1 - 25
  • $84.5M
  • $100K - 5M
View ProfileView
3
Evommune's Competitor - Vera logo

Marshall Fordyce

Founder & CEO

90/100
40
$524.3M
  • $524.3M
  • 40
    $524.3M
  • 90/100
  • 40
  • $524.3M
View ProfileView
4
Evommune's Competitor - Immune Design logo

Carlos Paya

President & CEO

82/100
25 - 100
$160.5M
$100K - 5M
  • $160.5M
    $100K - 5M
  • 25 - 100
    $160.5M
  • $100K - 5M
  • 82/100
  • 25 - 100
  • $160.5M
  • $100K - 5M
View ProfileView
5
Evommune's Competitor - Celgene logo

CEO

- -
5,000 - 10,000
- -
$10B - 50B
  • - -
    $10B - 50B
  • 5,000 - 10,000
    - -
  • $10B - 50B
  • - -
  • 5,000 - 10,000
  • - -
  • $10B - 50B
View ProfileView
Evommune's top 17 competitors are Ventyx, ValenzaBio, Vera, Cimt | Association For Cancer Immunotherapy, Immune Design, Celgene, MSI Methylation Sciences, Inovio, Escient, Sorrento, ViroPharma, Mustang Bio, Aura, Aurora Biopharma, Inc, Novartis, Perthera and Agenus. Together they have raised over 3.6B between their estimated 87.3K employees. Evommune's revenue is the ranked 13th among it's top 10 competitors. The top 10 competitors average 4.7B. Evommune has 30 employees and is ranked 14th among it's top 10 competitors. The top 10 competitors average 5,138.

Evommune VS Ventyx

Ventyx is Evommune's top competitor. Ventyx is headquartered in San Diego, California, and was founded in 2018. Like Evommune, Ventyx also operates in the Biotechnology field. Ventyx generates NaN% the revenue of Evommune.

Evommune VS ValenzaBio

ValenzaBio is seen as one of Evommune's top competitors. ValenzaBio's headquarters is in Bethesda, Maryland, and was founded in 2019. Like Evommune, ValenzaBio also works within the Biotechnology industry. ValenzaBio generates 111% of Evommune's revenue.

Evommune VS Vera

Vera has been one of Evommune's top competitors. Vera was founded in 2016, and its headquarters is in Brisbane, California. Like Evommune, Vera also works within the Biotechnology field. Vera has 10 more employees than Evommune.

Looking for similar companies to Evommune?

Similar Companies

Biotechnology companies in Palo Alto

See 74 companies 
Companies in Palo Alto with revenue in $100K-5.0M range

See 1,088 companies 
Pharmaceuticals & Biotechnology companies in Palo Alto

See 92 companies 
Biotechnology companies in San Francisco Bay Area

See 1,319 companies 
Pharmaceuticals & Biotechnology companies in San Francisco Bay Area

See 1,673 companies 
Companies in Palo Alto with employees in 25-100 range

See 1,952 companies 
Biotechnology companies in California

See 3,097 companies 
Pharmaceuticals & Biotechnology companies in California

See 4,181 companies 
Biotechnology companies with revenue in $100K-5.0M range

See 4,537 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for Evommune and Evommune's Competitors

April 9, 2025StreetInsider
PLYMOUTH MEETING, Pa., April 9, 2025 /PRNewswire/ --Â INOVIO (NASDAQ:......
April 8, 2025FinanzNachrichten
NORTHAMPTON, MA / ACCESS Newswire / April 8, 2025 / In 2019, Somchai, a Thai native, was 21 years old and faced a double threat to his long-term health...
April 7, 2025Pharmaceutical Business Review
This decision is based on the randomised MITIGATE trial data, which showed the antibody's potential to reduce disease activity by minimising flares in ...
April 9, 2025Openpr
The Diabetic Retinopathy Market is estimated to be valued at USD 9.91 Bn in 2025 and is expected to reach USD 15.40 Bn by 2032, exhibiting a compound a...
April 9, 2025Openpr
Latest Qualitative Research Report on the Patient Centric Healthcare App Market 2025, published by Coherent Market Insights, provides valuable insights...
April 9, 2025Tradingview
Amgen Inc AMGN : Amgen Inc AMGN : AMGEN INC SAYS CEO ROBERT A. BRADWAY'S 2024 TOTAL COMPENSATION WAS $24.4 MILLION- SEC FILING AMGEN INC SAYS CEO ROBER...
April 7, 2025Openpr
The Global Chronic Pain Market reached US$75.42 billion in 2024 and is expected to reach US$124.14 billion by 2032, growing at a CAGR of 6.9 % during t...

Frequently Asked Questions about Evommune

  1. Who are Evommune's top competitors?

    Evommune's top 3 competitors are Ventyx, ValenzaBio, Vera.

  2. Who is similar to Evommune?

    Ventyx is the most similar to Evommune. ValenzaBio and Vera are also similar to Evommune.

  1. Are Evommune and Ventyx competitors?

    Yes, Ventyx is one of Evommune’s top competitors.